Correlation of Urinary Engrailed-2 Levels to Tumour Volume and Pathological Stage in Men Undergoing Radical Prostatectomy

HTML  Download Download as PDF (Size: 951KB)  PP. 726-733  
DOI: 10.4236/jct.2013.43089    3,747 Downloads   5,640 Views  Citations

ABSTRACT

The aim of this study was to assess the relationship between pre-prostatectomy urinary Engrailed-2 (EN2), a transcription factor secreted by prostate cancer cells, with tumour volume and pathological characteristics in resected prostate specimens. First pass urine samples (10 ml) without prior prostatic massage were collected and stored at –80°C. EN2 levels were measured using an enzyme-linked immunoabsorbent assay. Tumour volume in the prostatectomy specimens was determined histologically. 57 men undergoing RP in one urological cancer network were evaluated. EN2 was detected in 85% of RP patients. EN2 correlated with tumour volume (but not total prostatic volume) in a linear regression analysis, with increasing pathological T stage and margin positivity. Using three cutoff levels of tumour volume (0.5 ml, 1.3 ml and 2.5 ml) to define significant disease, men with significant disease had markedly higher levels of urinary EN2 (p < 0.001 for each cut off level). Levels of urinary EN2 may be useful in predicting tumour volume in men with prostate cancer by potentially identifying men with small volume insignificant disease. This study justifies a larger multicentre evaluation of urinary EN2 levels as a biomarker of PC significance using cancer volume, pathological and PSA criteria.

Share and Cite:

H. Pandha, S. Javed, P. Sooriakumaran, S. Bott, B. Montgomery, A. Hutton, C. Eden, C. Eden, S. Langley and R. Morgan, "Correlation of Urinary Engrailed-2 Levels to Tumour Volume and Pathological Stage in Men Undergoing Radical Prostatectomy," Journal of Cancer Therapy, Vol. 4 No. 3, 2013, pp. 726-733. doi: 10.4236/jct.2013.43089.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.